Technical Analysis for CERT - Certara, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 16.28 | 0.74% | 0.12 |
Earnings due: May 6
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Flat | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 200 DMA Resistance | Bearish | 0.74% | |
| Lower Bollinger Band Walk | Weakness | 0.74% | |
| Outside Day | Range Expansion | 0.74% | |
| Lower Bollinger Band Touch | Weakness | 0.74% | |
| Oversold Stochastic | Weakness | 0.74% | |
| 200 DMA Resistance | Bearish | 2.20% | |
| Lower Bollinger Band Walk | Weakness | 2.20% | |
| Below Lower BB | Weakness | 2.20% | |
| Down 3 Days in a Row | Weakness | 2.20% | |
| Down 4 Days in a Row | Weakness | 2.20% |
| Alert | Time |
|---|---|
| 200 DMA Resistance | about 20 hours ago |
| Rose Above Previous Day's High | about 20 hours ago |
| Rose Above 200 DMA | about 20 hours ago |
| Outside Day | about 20 hours ago |
| Up 2% | about 21 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 05/06/2024
Certara, Inc. Description
Certara Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software and technology to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. The company serves biopharmaceutical companies and academic institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, and Australia. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Health Sciences Pharmacy Medication Drug Discovery Pharmacology Drug Development Pharmaceutical Sciences Systems Biology Medical Communications
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 24.7 |
| 52 Week Low | 11.81 |
| Average Volume | 543,867 |
| 200-Day Moving Average | 16.30 |
| 50-Day Moving Average | 17.77 |
| 20-Day Moving Average | 17.45 |
| 10-Day Moving Average | 17.28 |
| Average True Range | 0.66 |
| RSI (14) | 36.71 |
| ADX | 17.65 |
| +DI | 19.50 |
| -DI | 33.66 |
| Chandelier Exit (Long, 3 ATRs) | 17.20 |
| Chandelier Exit (Short, 3 ATRs) | 17.75 |
| Upper Bollinger Bands | 19.09 |
| Lower Bollinger Band | 15.82 |
| Percent B (%b) | 0.1 |
| BandWidth | 18.72 |
| MACD Line | -0.38 |
| MACD Signal Line | -0.15 |
| MACD Histogram | -0.2306 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 17.09 | ||||
| Resistance 3 (R3) | 17.07 | 16.73 | 16.94 | ||
| Resistance 2 (R2) | 16.73 | 16.50 | 16.75 | 16.88 | |
| Resistance 1 (R1) | 16.45 | 16.35 | 16.59 | 16.47 | 16.83 |
| Pivot Point | 16.11 | 16.11 | 16.19 | 16.13 | 16.11 |
| Support 1 (S1) | 15.83 | 15.88 | 15.97 | 15.85 | 15.49 |
| Support 2 (S2) | 15.49 | 15.73 | 15.51 | 15.44 | |
| Support 3 (S3) | 15.21 | 15.49 | 15.39 | ||
| Support 4 (S4) | 15.23 |
